Janis Liebetanz

Author PubWeight™ 15.90^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	In vivo antitumor activity of NVP-AEW541-A novel, potent, and selective inhibitor of the IGF-IR kinase.	Cancer Cell	2004	4.29
2	The crystal structure of a c-Src complex in an active conformation suggests possible steps in c-Src activation.	Structure	2005	2.78
3	Extended kinase profile and properties of the protein kinase inhibitor nilotinib.	Biochim Biophys Acta	2009	2.04
4	Structural biology contributions to the discovery of drugs to treat chronic myelogenous leukaemia.	Acta Crystallogr D Biol Crystallogr	2006	1.61
5	Imatinib (STI571) resistance in chronic myelogenous leukemia: molecular basis of the underlying mechanisms and potential strategies for treatment.	Mini Rev Med Chem	2004	1.26
6	Protein kinases as targets for anticancer agents: from inhibitors to useful drugs.	Pharmacol Ther	2002	1.22
7	Inhibitors of the Abl kinase directed at either the ATP- or myristate-binding site.	Biochim Biophys Acta	2010	1.16
8	Amino-acid-type selective isotope labeling of proteins expressed in Baculovirus-infected insect cells useful for NMR studies.	J Biomol NMR	2003	1.09
9	Improved expression of kinases in Baculovirus-infected insect cells upon addition of specific kinase inhibitors to the culture helpful for structural studies.	Protein Expr Purif	2007	0.87